AdvanSix Inc (NYSE:ASIX) Director Michael Marberry bought 1,806 shares of the stock in a transaction dated Wednesday, November 7th. The stock was bought at an average price of $27.65 per share, with a total value of $49,935.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Michael Marberry also recently made the following trade(s):
- On Friday, October 5th, Michael Marberry acquired 1,477 shares of AdvanSix stock. The shares were acquired at an average price of $33.81 per share, with a total value of $49,937.37.
- On Monday, September 10th, Michael Marberry acquired 1,434 shares of AdvanSix stock. The shares were acquired at an average price of $34.94 per share, with a total value of $50,103.96.
Shares of NYSE ASIX opened at $27.20 on Friday. AdvanSix Inc has a fifty-two week low of $22.84 and a fifty-two week high of $44.44. The company has a quick ratio of 0.70, a current ratio of 1.17 and a debt-to-equity ratio of 0.47. The company has a market cap of $852.06 million, a price-to-earnings ratio of 9.07 and a beta of 1.68.
AdvanSix (NYSE:ASIX) last issued its quarterly earnings data on Friday, November 2nd. The company reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.09). AdvanSix had a net margin of 7.86% and a return on equity of 16.18%. The business had revenue of $368.65 million for the quarter, compared to analyst estimates of $376.45 million. During the same quarter last year, the business earned $0.68 EPS. AdvanSix’s revenue for the quarter was up .5% compared to the same quarter last year. Equities analysts expect that AdvanSix Inc will post 2.53 earnings per share for the current fiscal year.
ASIX has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded AdvanSix from a “sell” rating to a “hold” rating in a research note on Thursday, August 30th. ValuEngine lowered AdvanSix from a “hold” rating to a “sell” rating in a research note on Friday, September 28th. Finally, TheStreet upgraded AdvanSix from a “c” rating to a “b-” rating in a research note on Tuesday, September 18th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the company. AdvanSix presently has an average rating of “Hold” and a consensus target price of $41.50.
Hedge funds and other institutional investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. acquired a new stake in AdvanSix during the 2nd quarter valued at approximately $134,000. Meeder Asset Management Inc. grew its position in shares of AdvanSix by 148.9% in the 2nd quarter. Meeder Asset Management Inc. now owns 4,142 shares of the company’s stock worth $152,000 after acquiring an additional 2,478 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of AdvanSix in the 3rd quarter worth approximately $150,000. Stevens Capital Management LP acquired a new position in shares of AdvanSix in the 2nd quarter worth approximately $204,000. Finally, Xact Kapitalforvaltning AB acquired a new position in shares of AdvanSix in the 2nd quarter worth approximately $210,000. Hedge funds and other institutional investors own 77.24% of the company’s stock.
AdvanSix Company Profile
AdvanSix Inc manufactures and sells polymer resins in the United States. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam, ammonium sulfate fertilizers, and acetone, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide.
Featured Article: How to interpret a stock’s beta number
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.